CD Bioparticles launches Organoid Construct Kits to the scientific community to facilitate the construction of complex organoid models.

CD Bioparticles launches new line of Stable-Isotope Labeled Particles to the scientific community.

CD Bioparticles announces its expanded capabilities in Customized Liposomes.

CD Bioparticles announces its advanced line of multiplex fluorescence particles.

CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.

CD Bioparticles announces the launch of its new line of Conjugated Agarose Particles for researchers.

CD Bioparticles is proud to announce the launch of its Polyacrylamides.

CD Bioparticles proudly announces the launch of its Agarose Particles for isolation and purification of proteins and antibodies.

Many clinical trials of mRNA-based drugs or vaccines have failed to successfully pass Phase I or Phase II.

Traditional immunoassays based on the format of 96-well microtiter plates are widely used in analytical laboratories and have become increasingly automated with the introduction of robotics technology in recent years, thereby enhancing assay throughput.

Poly(lactic-co-glycolic acid) (PLGA) is a functional polymer organic compound randomly polymerized by lactic acid (PLA) and glycolic acid (PGA).

POCT (Point-of-Care Testing) refers to clinical and bedside testing conducted in close proximity to patients.

Antibody-drug conjugates (ADCs) are conjugated products of monoclonal antibodies (mAbs) and cytotoxic small molecules.

Polystyrene particles (PSP) are commercially available in different sizes, ranging from 15 nanometers to several micrometers, with narrow size distributions and various surface chemistries.

As a promising systemic drug delivery method, transdermal drug delivery system (TDDS) is easier and more convenient to operate than traditional oral, intravenous and subcutaneous injection methods.